Logo image of OPXS

OPTEX SYSTEMS HOLDINGS INC (OPXS) Stock Fundamental Analysis

USA - NASDAQ:OPXS - US68384X2099 - Common Stock

15 USD
+0.77 (+5.41%)
Last: 10/13/2025, 7:13:13 PM
Fundamental Rating

6

Taking everything into account, OPXS scores 6 out of 10 in our fundamental rating. OPXS was compared to 69 industry peers in the Aerospace & Defense industry. OPXS gets an excellent profitability rating and is at the same time showing great financial health properties. OPXS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year OPXS was profitable.
In the past year OPXS had a positive cash flow from operations.
OPXS had positive earnings in each of the past 5 years.
Of the past 5 years OPXS 4 years had a positive operating cash flow.
OPXS Yearly Net Income VS EBIT VS OCF VS FCFOPXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of 17.60%, OPXS belongs to the top of the industry, outperforming 98.55% of the companies in the same industry.
OPXS's Return On Equity of 22.20% is amongst the best of the industry. OPXS outperforms 89.86% of its industry peers.
OPXS's Return On Invested Capital of 21.02% is amongst the best of the industry. OPXS outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OPXS is above the industry average of 8.28%.
The 3 year average ROIC (13.10%) for OPXS is below the current ROIC(21.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.6%
ROE 22.2%
ROIC 21.02%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
OPXS Yearly ROA, ROE, ROICOPXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 13.01%, OPXS belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
OPXS's Profit Margin has declined in the last couple of years.
The Operating Margin of OPXS (16.11%) is better than 85.51% of its industry peers.
In the last couple of years the Operating Margin of OPXS has grown nicely.
OPXS's Gross Margin of 28.02% is fine compared to the rest of the industry. OPXS outperforms 62.32% of its industry peers.
OPXS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.11%
PM (TTM) 13.01%
GM 28.02%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
OPXS Yearly Profit, Operating, Gross MarginsOPXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OPXS is creating value.
The number of shares outstanding for OPXS has been increased compared to 1 year ago.
OPXS has less shares outstanding than it did 5 years ago.
OPXS has a better debt/assets ratio than last year.
OPXS Yearly Shares OutstandingOPXS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
OPXS Yearly Total Debt VS Total AssetsOPXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 12.70 indicates that OPXS is not in any danger for bankruptcy at the moment.
OPXS's Altman-Z score of 12.70 is amongst the best of the industry. OPXS outperforms 86.96% of its industry peers.
OPXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.7
ROIC/WACC2.18
WACC9.66%
OPXS Yearly LT Debt VS Equity VS FCFOPXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 5.14 indicates that OPXS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.14, OPXS belongs to the top of the industry, outperforming 92.75% of the companies in the same industry.
OPXS has a Quick Ratio of 2.05. This indicates that OPXS is financially healthy and has no problem in meeting its short term obligations.
OPXS's Quick ratio of 2.05 is fine compared to the rest of the industry. OPXS outperforms 69.57% of its industry peers.
Industry RankSector Rank
Current Ratio 5.14
Quick Ratio 2.05
OPXS Yearly Current Assets VS Current LiabilitesOPXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.09% over the past year.
OPXS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.27% yearly.
Looking at the last year, OPXS shows a very strong growth in Revenue. The Revenue has grown by 21.00%.
The Revenue has been growing slightly by 6.74% on average over the past years.
EPS 1Y (TTM)21.09%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%21.06%
Revenue 1Y (TTM)21%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%22.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPXS Yearly Revenue VS EstimatesOPXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.27, which indicates a rather expensive current valuation of OPXS.
OPXS's Price/Earnings ratio is rather cheap when compared to the industry. OPXS is cheaper than 91.30% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.35. OPXS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.27
Fwd PE N/A
OPXS Price Earnings VS Forward Price EarningsOPXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OPXS is valued cheaply inside the industry as 92.75% of the companies are valued more expensively.
97.10% of the companies in the same industry are more expensive than OPXS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.11
EV/EBITDA 13.55
OPXS Per share dataOPXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The excellent profitability rating of OPXS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.75
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OPXS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OPTEX SYSTEMS HOLDINGS INC

NASDAQ:OPXS (10/13/2025, 7:13:13 PM)

15

+0.77 (+5.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)12-17 2025-12-17
Inst Owners35.42%
Inst Owner Change0.01%
Ins Owners17.43%
Ins Owner Change-5.4%
Market Cap103.65M
AnalystsN/A
Price TargetN/A
Short Float %0.34%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.27
Fwd PE N/A
P/S 2.63
P/FCF 19.11
P/OCF 16.94
P/B 4.48
P/tB 4.65
EV/EBITDA 13.55
EPS(TTM)0.74
EY4.93%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.79
FCFY5.23%
OCF(TTM)0.89
OCFY5.9%
SpS5.71
BVpS3.35
TBVpS3.23
PEG (NY)N/A
PEG (5Y)4.75
Profitability
Industry RankSector Rank
ROA 17.6%
ROE 22.2%
ROCE 25.99%
ROIC 21.02%
ROICexc 26.24%
ROICexgc 27.42%
OM 16.11%
PM (TTM) 13.01%
GM 28.02%
FCFM 13.74%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
ROICexc(3y)13.88%
ROICexc(5y)N/A
ROICexgc(3y)14.18%
ROICexgc(5y)N/A
ROCE(3y)16.55%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.64%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.31%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 130.21%
Cap/Sales 1.76%
Interest Coverage 219.38
Cash Conversion 88.75%
Profit Quality 105.63%
Current Ratio 5.14
Quick Ratio 2.05
Altman-Z 12.7
F-Score7
WACC9.66%
ROIC/WACC2.18
Cap/Depr(3y)182.71%
Cap/Depr(5y)142.72%
Cap/Sales(3y)2.57%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.09%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%21.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%22.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.62%
EBIT growth 3YN/A
EBIT growth 5Y8.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y431.2%
FCF growth 3Y-37.72%
FCF growth 5Y24.08%
OCF growth 1Y589.91%
OCF growth 3Y54.71%
OCF growth 5Y61.92%